Ingenix releases Thalamus Decision for cellular aging research
The AMW Read
The release adds a biology-focused model, but its license and independent performance evidence remain unclear.
Ingenix releases Thalamus Decision for cellular aging research
Warsaw-based Ingenix released Thalamus Decision on November 9, 2026, for researchers studying cellular aging. The company describes the model as open source and says it wants academic and commercial teams to inspect, reproduce, and build on its work. The available coverage does not specify the license, price, or hardware requirements.
The release adds a specialized model to the market for AI tools in biology, where researchers must assess both domain performance and the evidence behind it. A related 9 billion parameter model, Thalamus Reasoning, reportedly ranked first among 29 models on LongevityBench, a benchmark for language models in cellular aging research. That result belongs to Thalamus Reasoning, not necessarily to the released Decision model. Independent verification of the ranking was not established in the coverage provided.
For research teams and investors, the immediate question is whether the release can be evaluated and used under clear terms. Teams considering it should check the license and hardware requirements and test Decision on their own aging research tasks before relying on the reported result for the related model. Ingenix also says it is developing a 95 billion parameter model, but the available coverage gives no release date or price.